Nano-X Imaging Ltd. (NASDAQ:NNOX - Free Report) - Research analysts at Cantor Fitzgerald issued their FY2025 earnings estimates for Nano-X Imaging in a report issued on Tuesday, January 21st. Cantor Fitzgerald analyst R. Osborn expects that the company will post earnings of ($0.61) per share for the year. Cantor Fitzgerald has a "Overweight" rating and a $12.00 price objective on the stock. The consensus estimate for Nano-X Imaging's current full-year earnings is ($0.92) per share.
Separately, D. Boral Capital assumed coverage on shares of Nano-X Imaging in a research note on Monday, January 6th. They set a "buy" rating and a $23.00 target price for the company.
Read Our Latest Analysis on NNOX
Nano-X Imaging Trading Down 5.8 %
Shares of NNOX stock traded down $0.51 on Thursday, reaching $8.24. 2,732,064 shares of the company's stock were exchanged, compared to its average volume of 4,718,643. The company's fifty day simple moving average is $7.37 and its 200 day simple moving average is $6.95. Nano-X Imaging has a 52 week low of $5.26 and a 52 week high of $14.28. The stock has a market capitalization of $476.11 million, a PE ratio of -9.69 and a beta of 1.97.
Nano-X Imaging (NASDAQ:NNOX - Get Free Report) last issued its quarterly earnings results on Thursday, November 21st. The company reported ($0.23) EPS for the quarter. Nano-X Imaging had a negative net margin of 465.38% and a negative return on equity of 27.63%. During the same quarter in the prior year, the company earned ($0.37) EPS.
Hedge Funds Weigh In On Nano-X Imaging
Several institutional investors have recently made changes to their positions in the company. Farther Finance Advisors LLC purchased a new position in Nano-X Imaging during the 3rd quarter valued at about $25,000. Gainplan LLC bought a new position in Nano-X Imaging in the fourth quarter worth approximately $92,000. Verition Fund Management LLC bought a new stake in Nano-X Imaging during the 3rd quarter valued at $88,000. Creative Planning purchased a new position in shares of Nano-X Imaging in the 3rd quarter valued at $107,000. Finally, The Manufacturers Life Insurance Company raised its position in shares of Nano-X Imaging by 14.8% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 20,210 shares of the company's stock worth $148,000 after acquiring an additional 2,600 shares in the last quarter. Hedge funds and other institutional investors own 21.49% of the company's stock.
Nano-X Imaging Company Profile
(
Get Free Report)
Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. The company provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. Its X-ray source is based on a digital micro-electro-mechanical systems semiconductor cathode.
Recommended Stories
Before you consider Nano-X Imaging, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nano-X Imaging wasn't on the list.
While Nano-X Imaging currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.